Cycloheximide rapidly inhibits cortical COX activity and COX-dependent pial arteriolar dilation in piglets

1  Department of Physiology and Pharmacology, 2  Department of Pediatrics, and 3  Stroke Research Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1010; 4  Department of Physiology, Albert Szent-Györgyi Medical University, Szeged, H-6720 Hungary; and 5  Departme...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Heart and circulatory physiology 1999-09, Vol.277 (3), p.H1113-H1118
Hauptverfasser: Domoki, Ferenc, Perciaccante, James V, Veltkamp, Roland, Robins, Greg, Bari, Ferenc, Louis, Thomas M, Busija, David W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:1  Department of Physiology and Pharmacology, 2  Department of Pediatrics, and 3  Stroke Research Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1010; 4  Department of Physiology, Albert Szent-Györgyi Medical University, Szeged, H-6720 Hungary; and 5  Department of Anatomy and Cell Biology, East Carolina University, School of Medicine, Greenville, North Carolina 27858-4353 We have previously shown that cycloheximide (CHX) preserved neuronal function after global cerebral ischemia in piglets, in a manner similar to indomethacin. To elucidate the mechanism of this protection, we tested the hypothesis that CHX would inhibit cyclooxygenase (COX) activity in the piglet cerebral cortex and vasculature. Pial arteriolar responses to hypercapnia, arterial hypotension, and sodium nitroprusside (SNP) were determined before and 20 min after treatment with CHX (0.3-1 mg/kg iv) using a closed cranial window and intravital microscopy. We also determined baseline and arachidonic acid (AA)-stimulated cortical PGF 2 and 6-keto-PGF 1 production before and 20-60 min after CHX (1 mg/kg iv) treatment, using ELISA kits. CHX did not affect baseline diameters (~100 µm) but significantly decreased arteriolar dilation to COX-dependent stimuli, such as hypercapnia and hypotension, but not to COX-independent SNP. In the 1 mg/kg CHX-treated group, increases in vascular diameters were reduced from 22 ± 2 to 10 ± 2%, from 49 ± 5 to 31 ± 3% (means   ± SE, 5 and 10% CO 2 , respectively, n  = 8), from 12 ± 3 to 3 ±   1%, and from 26 ± 5 to 6 ± 2% (~25 and 40% decreases in blood pressure, respectively, n  = 6). CHX also inhibited conversion of exogenous AA to both PGF 2 and 6-keto-PGF 1 ; for example, 20 min after CHX treatment 10 µg/ml AA-stimulated PGF 2 concentrations in the artificial cerebrospinal fluid decreased from 14.28 ± 3.04   to 5.90 ± 1.26 ng/ml ( n  = 9). Thus CHX rapidly decreases COX activity in the piglet cerebral cortex. This result may explain in part the preservation of neuronal function of CHX in cerebral ischemia. cerebral blood flow; arachidonic acid; hypercapnia; arterial hypotension; prostaglandin H synthase
ISSN:0363-6135
0002-9513
1522-1539
DOI:10.1152/ajpheart.1999.277.3.H1113